Press release
Obesity Market to Witness Growth by 2032, asserts DelveInsight | Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics
DelveInsight's "Obesity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Obesity, historical and forecasted epidemiology as well as the Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.The Obesity market report provides current treatment practices, emerging drugs, Obesity market share of the individual therapies, and current and forecasted Obesity market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Obesity market.
Request for a Free Sample Report @ https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Obesity Overview
Obesity is a chronic medical condition characterized by excessive accumulation of body fat, leading to adverse effects on health. Here's an overview of obesity, including its causes, signs and symptoms, diagnosis, and treatment options:
Obesity Overview:
Obesity is a complex disorder influenced by genetic, environmental, behavioral, and hormonal factors.
It is defined by body mass index (BMI), calculated as weight in kilograms divided by height in meters squared (kg/m^2). A BMI of 30 or higher is considered obese.
Obesity is associated with numerous health complications, including type 2 diabetes, hypertension, heart disease, stroke, certain cancers, sleep apnea, osteoarthritis, and mental health disorders.
Obesity Causes:
Genetic factors: Family history and genetic predisposition can contribute to obesity.
Environmental factors: Access to unhealthy food options, sedentary lifestyle, socioeconomic status, and cultural influences can all play a role.
Behavioral factors: Overeating, poor dietary choices, lack of physical activity, and unhealthy lifestyle habits contribute to weight gain.
Hormonal factors: Imbalances in hormones such as leptin, insulin, and ghrelin can affect appetite regulation and metabolism.
Obesity Signs and Symptoms:
Increased body weight and BMI
Excessive fat accumulation, especially around the abdomen, hips, and thighs
Breathlessness
Fatigue
Joint pain
Snoring or sleep disturbances
Low self-esteem or depression
Difficulty performing daily activities
Obesity Diagnosis:
Diagnosis of obesity involves assessing BMI, waist circumference, and evaluating other risk factors for obesity-related complications such as hypertension, dyslipidemia, and diabetes.
Additional tests may include blood tests to assess glucose and lipid levels, thyroid function tests, and screening for obesity-related complications.
Obesity Treatment Options:
Lifestyle modifications: Adopting a healthy diet rich in fruits, vegetables, lean proteins, and whole grains while limiting processed foods, sugary beverages, and high-calorie snacks. Regular physical activity, such as aerobic exercise and strength training, is also essential for weight management.
Behavioral therapy: Counseling and behavioral interventions can help individuals develop healthy eating habits, improve portion control, and manage stress or emotional eating.
Medications: Prescription medications may be recommended for individuals with obesity and obesity-related complications who have not achieved sufficient weight loss through diet and exercise alone. These medications work by suppressing appetite, reducing fat absorption, or increasing feelings of fullness.
Bariatric surgery: Surgical interventions such as gastric bypass, gastric sleeve, or gastric banding may be considered for individuals with severe obesity or obesity-related complications who have not responded to other treatment options. These procedures restrict food intake or reduce nutrient absorption to promote weight loss.
Effective management of obesity requires a comprehensive approach that addresses underlying causes, promotes healthy lifestyle habits, and incorporates medical interventions when necessary. Long-term success depends on sustained adherence to dietary and exercise recommendations, regular monitoring, and ongoing support from healthcare providers.
Visit to know more about Obesity, treatment algorithms in different geographies, and patient journey contact to receive a sample @ https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Obesity Market
The Obesity market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Obesity market trends by analyzing the impact of current Obesity therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
This segment gives a thorough detail of the Obesity market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Obesity market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Obesity market in 7MM is expected to witness a major change in the study period 2019-2032.
Request a sample and discover more about the report offerings at:
https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Obesity Epidemiology
The Obesity epidemiology section provides insights into the historical and current Obesity patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Obesity market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Explore more about the Obesity Epidemiology at: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Obesity Drugs Uptake
This section focuses on the rate of uptake of the potential Obesity drugs recently launched in the Obesity market or expected to get launched in the market during the study period 2019-2032. The analysis covers the Obesity market uptake by drugs; patient uptake by therapies; and sales of each drug.
Obesity Drugs Uptake helps in understanding the drugs with the most rapid uptake, and the reasons behind the maximal use of new drugs, and allows the comparison of the drugs on the basis of Obesity market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Obesity Pipeline Development Activities
The Obesity report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Obesity key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Obesity pipeline development activities at: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Obesity Therapeutics Assessment
Major pharma players such as Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis, CSPC Baike (Shandong) Biopharmaceutical, Jiangsu HengRui Medicine, Carmot Therapeutics, Pfizer, Sciwind Biosciences, Empros Pharma, and others are working proactively in the Obesity therapeutics market to develop novel therapies which will drive the Obesity treatment market in the upcoming years.
Learn more about the emerging therapies & key companies at: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Obesity Report Key Insights
1. Obesity Patient Population
2. Obesity Market Size and Trends
3. Key Cross Competition in the Obesity Market
4. Obesity Market Dynamics (Key Drivers and Barriers)
5. Obesity Market Opportunities
6. Obesity Therapeutic Approaches
7. Obesity Pipeline Analysis
8. Obesity Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Obesity Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Obesity Competitive Intelligence Analysis
4. Obesity Market Overview at a Glance
5. Obesity Disease Background and Overview
6. Obesity Patient Journey
7. Obesity Epidemiology and Patient Population
8. Obesity Treatment Algorithm, Current Treatment, and Medical Practices
9. Obesity Unmet Needs
10. Key Endpoints of Obesity Treatment
11. Obesity Marketed Products
12. Obesity Emerging Therapies
13. Obesity Seven Major Market Analysis
14. Attribute Analysis
15. Obesity Market Outlook (7 major markets)
16. Obesity Access and Reimbursement Overview
17. KOL Views on the Obesity Market
18. Obesity Market Drivers
19. Obesity Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Get the Detailed TOC of the Obesity Market report here: https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us:
Kritika Rehani
info@delveinsight.com
+91-9650213330
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obesity Market to Witness Growth by 2032, asserts DelveInsight | Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics here
News-ID: 3467308 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Obesity
Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti Obesity Drugs Market Overview:
The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.…
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success.
Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss.
Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg
Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With…
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930
This latest report researches the industry structure,…
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which…
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle…
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close…